Search for another bill

Search for another bill or initiative


SB 5020 - 2021-22

Assessing a penalty on unsupported prescription drug price increases to protect the safety, health, and economic well-being of Washington residents.
Sponsors: Keiser, Robinson, Conway, Das, Hasegawa, Kuderer, Lovelett, Rolfes, Stanford, Van De Wege, Wilson, C.

Bill history

2021 Regular Session

In the Senate

Dec 17
Prefiled for introduction.
Jan 11
First reading, referred to Health & Long Term Care. (View original bill)
Jan 22
Public hearing in the Senate Committee on Health & Long Term Care at 8:00 AM. (Committee materials)
Feb 12
Executive action taken in the Senate Committee on Health & Long Term Care at 8:00 AM. (Committee materials)
HLTC - Majority; 1st substitute bill be substituted, do pass. (View 1st substitute) (Majority report)
Minority; do not pass. (Minority report)
Minority; without recommendation. (Minority report)
And refer to Ways & Means.
Feb 15
Referred to Ways & Means.

2022 Regular Session

In the Senate

Jan 10
By resolution, reintroduced and retained in present status.

Available documents

For a complete list of documents, go to Detailed Legislative Reports Text of a legislative document.

Fiscal note

Amendments

Available videos